Wellgistics Health, Inc. Common Stock
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, … Read more
Wellgistics Health, Inc. Common Stock (WGRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.168x
Based on the latest financial reports, Wellgistics Health, Inc. Common Stock (WGRX) has a cash flow conversion efficiency ratio of -0.168x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.14 Million) by net assets ($6.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Wellgistics Health, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Wellgistics Health, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Wellgistics Health, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wellgistics Health, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nexus Uranium Corp.
F:JA7
|
-0.081x |
|
Comet Industries Ltd
V:CMU
|
-0.002x |
|
NINtec Systems Limited
NSE:NINSYS
|
N/A |
|
Sparta Commercial Services Inc
PINK:SRCO
|
0.018x |
|
Redsense Medical AB (publ)
OTCGREY:RDSNF
|
-0.159x |
|
Bulletin Resources Ltd
AU:BNR
|
-0.046x |
|
Pan Asia Footwear Public Company Limited
BK:PAF
|
0.058x |
|
ViroGates A/S
CO:VIRO
|
-0.879x |
Annual Cash Flow Conversion Efficiency for Wellgistics Health, Inc. Common Stock (2022–2024)
The table below shows the annual cash flow conversion efficiency of Wellgistics Health, Inc. Common Stock from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $6.73 Million | $-1.22 Million | -0.182x | -251.11% |
| 2023-12-31 | $-2.90 Million | $-349.14K | 0.120x | -- |
| 2022-12-31 | $-5.25K | $0.00 | 0.000x | -- |